News
The SCOOTER Store Creates Home Care Equipment Division
September 2, 2010 11:35 am | by Bio-Medicine.Org | CommentsNEW BRAUNFELS, Texas, Sept. 2 /- The SCOOTER Store, the nation's largest provider of power mobility products and services, has announced the creation of a new internal division focusing on Home Care equipment, accessories and related services to complement its traditional power mobility...
Ascension Orthopedics Receives FDA Approval for TITAN™ Modular Total Shoulder System
September 2, 2010 11:34 am | by Bio-Medicine.Org | CommentsAUSTIN, Texas, Sept. 2 /- Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic devices, announces FDA approval to market the TITAN™ Modular Total Shoulder System. This newly designed system redefines modularity by providing multiple surgical solutions for shoulder...
Mark S. Rangell Appointed Chief Operating Officer for Sandata Technologies, LLC
September 2, 2010 11:33 am | by Bio-Medicine.Org | CommentsPORT WASHINGTON, N.Y., Sept. 2 /- Sandata Technologies, LLC, a leading national provider of information technology solutions to the home healthcare community, today announced the hiring of Mark S. Rangell as its Chief Operating Officer. Mr. Rangell will be in charge of Sandata's...
CLC bio expands Cambridge office, looks to hire
September 2, 2010 9:33 am | by Mass High Tech: The Journal of New England Technology | CommentsDenmark-based CLC bio, a life sciences services company providing hardware, software and data analytics, is expanding its presence in Cambridge with a new North American headquarters location.
Guidance for Industry and FDA Staff - Impact-Resistant Lenses: Questions and Answers
September 2, 2010 9:32 am | by U.S. Food & Drug Administration | CommentsEyeglasses and sunglasses (eyewear) that are intended to affect the structure or function of the body or intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, are devices...
Federal Register: Guidance for Industry and Food and Drug Administration Staff; Impact-Resistant Lenses: Questions and Answers; Availability.
September 2, 2010 9:32 am | by U.S. Food & Drug Administration | CommentsThe FDA is announcing the availability of the guidance entitled 'Impact-Resistant Lenses: Questions and Answers.' This guidance document answers manufacturer, importer, and consumer questions on impact-resistant lenses, including questions on test...
Transdel Pharmaceuticals Presents Phase 3 Study Data on Ketotransdel® at World Pain Congress in Montreal, Canada
September 2, 2010 6:32 am | by Bio-Medicine.Org | CommentsMONTREAL, Sept. 2 /- Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP ), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, announced today the final data set from its Phase 3 study of...
NewCardio CEO Increases Equity Position
September 2, 2010 6:32 am | by Bio-Medicine.Org | CommentsSANTA CLARA, Calif., Sept. 2 /- NewCardio (OTC Bulletin Board: NWCI ) a cardiac diagnostic technology provider, today announced that Vincent Renz, Jr., NewCardio's President and CEO, purchased 128,000 shares during his trading window in open market transactions in the two weeks following...
Daxor Announces Third Quarter Dividend and Update on Use of Blood Volume Analyzer in Heart Failure
September 2, 2010 4:45 am | by The Associated Press | CommentsDaxor Corporation (NYSE Amex: DXR), a medical instrumentation and biotechnology company, today announced that the Board of Directors has voted to declare a dividend of $0.25 per share. The dividend will be paid to shareholders of record as of Wednesday, September 15, 2010. The dividend...
Office of Device Evaluation Annual Performance Report Fiscal Year 2009
September 2, 2010 4:35 am | by U.S. Food & Drug Administration | CommentsIn the past, the ODE Annual Report included information from and about the ODE Review Divisions, our initiatives, and data analysis from the ODE Program Operations Staff (POS). The FY 09 Report only includes data from POS on our premarket review program.
Canadian Pharmacy Intermediary SaveRxCanada.com Enhances Online Shopping System
September 2, 2010 3:32 am | by Bio-Medicine.Org | CommentsMIAMI, Sept. 2 /- SaveRxCanada.com, the premier Canadian pharmacy intermediary since 2004, announced an enhancement to its full online shopping system. SaveRxCanada.com has been at the forefront of connecting consumers to affordable Canada drugs though its unique network of licensed...
13th Annual Henry Schein Back-to-School Program Serves Record Number of Children
September 2, 2010 3:32 am | by Bio-Medicine.Org | CommentsMELVILLE, N.Y., Sept. 2 /- Henry Schein, Inc. (Nasdaq: HSIC ), the largest provider of health care products and services to office-based practitioners, is helping a record number of children return to school wearing new outfits and carrying backpacks filled with school supplies and...
Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
September 2, 2010 1:34 am | by Bio-Medicine.Org | CommentsSAN DIEGO and OSAKA, Japan, Sept. 2 /- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) and Takeda Pharmaceutical Company Limited (TSE: 4502), today announced that they have entered into an exclusive partnership to develop and commercialize Contrave® (naltrexone SR/bupropion SR),...
Groundbreaking RF MEMS start-up DelfMEMS secures $1.9M funding
September 1, 2010 11:33 pm | by I-Micronews | CommentsDelfMEMS, a rising player in the field of Radiofrequency components and developer of innovative MEMS (Micro-Electro-Mechanical-Systems) switching solutions, announces that the company has secured 1.5M? ($1,9M) in venture capital (VC) funds.
OptiML? wafer-level packaging from Tessera
September 1, 2010 11:33 pm | by I-Micronews | CommentsMany electronic devices, including digital cameras, incorporate image sensors. Tessera's OptiML wafer-level packaging technology makes it possible to create image sensors that are thinner, more reliable and less expensive.
